Author: Marian Andrecki

Mail-order generics offer home delivery of medications but come with hidden risks like temperature damage and pricing markups. Learn how to use them safely for chronic conditions while avoiding common pitfalls.

Exploring the risks and challenges of generic cyclosporine and tacrolimus for transplant patients. Learn why bioequivalence issues, dosing differences, and switching protocols matter for safety and effectiveness.

Learn how to cut prescription costs during Medicare Part D’s donut hole in 2024 before the $2,000 out-of-pocket cap eliminates it in 2025. Proven strategies for saving hundreds or thousands on meds.

SGLT2 inhibitors help lower blood sugar and protect the heart and kidneys in type 2 diabetes, but come with risks like yeast infections and rare but serious ketoacidosis. Know who benefits most and what to watch for.

Salt substitutes with potassium chloride can cause dangerous potassium buildup when taken with ACE inhibitors or ARBs, especially for people with kidney disease. Learn who’s at risk and what safer alternatives exist.

Most people who think they're allergic to penicillin aren't. Learn how true drug allergies work, why NSAID reactions are different, and how desensitization can save lives when no other options exist.

Cognitive decline screening has evolved beyond paper tests. In 2026, digital tools and blood biomarkers now detect Mild Cognitive Impairment earlier than ever - crucial for new Alzheimer’s treatments. Here’s what works, what’s next, and how to ask for it.

Community health presentations are helping patients understand that generic drugs are just as safe and effective as brand-name versions-saving billions and improving adherence. Learn the facts, bust the myths, and see how public education is changing lives.

Computer vision syndrome causes eye strain, dry eyes, and headaches from prolonged screen use. Learn proven ways to prevent it with the 20-20-20 rule, proper screen setup, and eye care tips.

States are using MAC lists, price-gouging laws, and PBM transparency rules to control Medicaid spending on generic drugs. With 85% of prescriptions being generics, these strategies save billions - but supply chain risks remain.